PHS
NVDA icon

PFM Health Sciences’s NVIDIA NVDA Stock Holding History

PFM Health Sciences’s Portfolio NVDA Stock Details NVDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,036,440
Closed -$14M – 97
2020
Q3 		$14M Sell
1,036,440
-488,080
-32% -$5.68M 0.65% 52
2020
Q2 		$14.5M Sell
1,524,520
-949,160
-38% -$7.68M 0.75% 50
2020
Q1 		$16.3M Buy
2,473,680
+878,120
+55% +$5.54M 1.34% 31
2019
Q4 		$9.39M Buy
+1,595,560
New +$8.3M 0.45% 51
2018
Q4 		– Sell
-4,550,120
Closed -$32M – 117
2018
Q3 		$32M Sell
4,550,120
-636,040
-12% -$4.14M 0.47% 75
2018
Q2 		$30.7M Buy
5,186,160
+2,522,080
+95% +$15.3M 0.48% 75
2018
Q1 		$15.4M Sell
2,664,080
-3,117,240
-54% -$18.3M 0.31% 78
2017
Q4 		$28M Buy
5,781,320
+803,960
+16% +$3.99M 0.66% 52
2017
Q3 		$22.2M Buy
4,977,360
+899,400
+22% +$3.74M 0.44% 66
2017
Q2 		$14.7M Buy
+4,077,960
New +$13M 0.4% 67
2015
Q1 		– Sell
-29,057,200
Closed -$14.6M – 96
2014
Q4 		$14.6M Buy
+29,057,200
New +$14.2M 0.34% 69

Other funds holding NVDA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PFM Health Sciences's NVDA Position: Q4 2020 in Review

PFM Health Sciences sold out of NVIDIA (NVDA) in Q4 2020, closing a stake of 1,036,440 shares — an estimated $14M sold.

PFM Health Sciences first reported a position in NVDA in Q4 2014 and held it in 11 quarters. The position peaked at $32M in Q3 2018. 2,309 funds tracked by Wall St. Rank hold NVDA as of Q4 2020.

  • PFM Health Sciences reported no remaining NVIDIA position as of Q4 2020 after selling out during the quarter.
  • PFM Health Sciences sold 1,036,440 NVIDIA shares in Q4 2020, an estimated $14M.
  • PFM Health Sciences first reported a position in NVIDIA in Q4 2014 and held it in 11 quarters.
  • PFM Health Sciences's NVIDIA position peaked at $32M in Q3 2018.
  • 2,309 funds tracked by Wall St. Rank held NVIDIA as of Q4 2020.

Based on PFM Health Sciences's 13F filing for Q4 2020, filed 16 Feb 2021.